NCT00788931View on ClinicalTrials.gov

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2010

Conditions
HER-2 Positive Breast CancerMetastatic Breast Cancer
Interventions
DRUG

IV LBH589

DRUG

Oral LBH589

DRUG

trastuzumab

DRUG

paclitaxel

Trial Locations (7)

1000

Novartis Investigative Site, Brussels

4000

Novartis Investigative Site, Liège

5011

Novartis Investigative Site, Woodville

33081

Novartis Investigative Site, Aviano

36688

Novartis Investigative Site, Mobile

62100

Novartis Investigative Site, Macerata

1066 CX

Novartis Investigative Site, Amsterdam

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY